Get the Stockscreener App
1.21
7.08%
0.08
Pre-market:
1.30
0.09
+7.44%
Revelation Biosciences Inc stock is traded at $1.21, with a volume of 110.45K.
It is up +7.08% in the last 24 hours and down -6.20% over the past month.
Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.
See More
Previous Close:
$1.13
Open:
$1.15
24h Volume:
110.45K
Relative Volume:
0.19
Market Cap:
$4.50M
Revenue:
-
Net Income/Loss:
$-8.91M
P/E Ratio:
-0.0311
EPS:
-38.8702
Net Cash Flow:
$-8.27M
1W Performance:
-1.63%
1M Performance:
-6.20%
6M Performance:
-79.42%
1Y Performance:
-91.80%
1-Day Range:
$1.13
$1.27
1-Week Range:
$1.10
$1.27
52-Week Range:
$1.06
$14.72
Revelation Biosciences Inc Stock (REVB) Company Profile
Name
Revelation Biosciences Inc
Sector
Industry
Phone
650-800-3717
Address
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Compare REVB vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
1.21 | 4.50M | 0 | -8.91M | -8.27M | -38.87 |
VRTX
Vertex Pharmaceuticals Inc
|
443.92 | 112.92B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
775.53 | 81.99B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
785.07 | 48.82B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
327.25 | 43.66B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
312.19 | 34.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Revelation Biosciences Inc Stock (REVB) Latest News
Stock Market Recap: Can Revelation Biosciences Inc keep up with sector leadersWeekly Profit Analysis & Smart Swing Trading Alerts - baoquankhu1.vn
US Market Wrap: Is Revelation Biosciences Inc Equity Warrant showing insider buyingWeekly Trade Analysis & Real-Time Price Movement Reports - baoquankhu1.vn
Revelation Biosciences forms advisory board for AKI trial By Investing.com - Investing.com Australia
Chart Watch: Does Revelation Biosciences Inc Equity Warrant stock benefit from AI growthDip Buying & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Revelation Biosciences Forms Acute Kidney Injury Advisory Board - National Today
Revelation Biosciences forms advisory board for AKI trial - Investing.com
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board - Weatherford Democrat
Kidney injury trial draws 5 specialists to guide Revelation study - Stock Titan
REVB SEC FilingsRevelation Biosciences 10-K, 10-Q, 8-K Forms - stocktitan.net
REVB Technical Analysis & Stock Price Forecast - Intellectia AI
Aug Wrap: Will Revelation Biosciences Inc Equity Warrant benefit from green energy policies2026 Trade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn
History Review: What is Revelation Biosciences Inc Equity Warrants valuation compared to sectorWeekly Investment Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Short Squeeze: Is Revelation Biosciences Inc Equity Warrant backed by strong institutional buying2026 Momentum & Stepwise Trade Signal Implementation - baoquankhu1.vn
Returns Recap: Is Revelation Biosciences Inc Equity Warrant stock influenced by commodity prices2026 Short Interest & Weekly Breakout Watchlists - baoquankhu1.vn
Sectors Review: What are the risks of holding Revelation Biosciences IncTrade Exit Summary & Smart Investment Allocation Tips - baoquankhu1.vn
Aug Closing: Can Revelation Biosciences Inc Equity Warrant grow without dilution2026 Momentum Check & Community Shared Stock Ideas - baoquankhu1.vn
Revelation Biosciences Presents Positive Data from Prime Clinical Study - National Today
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study - ACCESS Newswire
A single Gemini dose restored immune response for 7 days in CKD study - Stock Titan
Fund Flows: How does Revelation Biosciences Inc Equity Warrant compare to its peersTrade Volume Summary & Smart Swing Trading Alerts - baoquankhu1.vn
REVB Should I Buy - Intellectia AI
Growth Report: How does Revelation Biosciences Inc Equity Warrant compare to its peersQuarterly Portfolio Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn
REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference - thenewstribune.com
Revelation Biosciences' Roth fireside chat streams live at 2 p.m. PT - Stock Titan
If You Invested $1,000 in Revelation Biosciences (REVB) - Stock Titan
Aug Momentum: Is Revelation Biosciences Inc Equity Warrant showing insider buyingPortfolio Update Summary & Community Trade Idea Sharing - baoquankhu1.vn
Revelation Biosciences, Inc.: Fundamental Analysis and Financial Ratings | | US76135L7055 - marketscreener.com
Swing Trade: What makes Revelation Biosciences Inc stock attractive today2026 Earnings Surprises & Accurate Technical Buy Alerts - baoquankhu1.vn
Aug Patterns: How does Revelation Biosciences Inc Equity Warrant compare to its peersRate Hike & Daily Market Momentum Tracking - baoquankhu1.vn
Revelation Biosciences stockholders approve warrant issuance beyond Nasdaq cap By Investing.com - Investing.com India
Revelation Biosciences, Inc. 8-K SEC Filing March 2026 – Company Information, Address, and Security Details - Minichart
Revelation Biosciences stockholders approve warrant issuance beyond Nasdaq cap - Investing.com
Revelation Biosciences (NASDAQ: REVB) clears Class J warrant share issuance - Stock Titan
Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference - ACCESS Newswire
Revelation Biosciences CEO, CFO to appear in Mar. 24 webcast chat - Stock Titan
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Gardner News
Aug Breakouts: Can Revelation Biosciences Inc beat the S P 500Trade Risk Summary & Smart Allocation Stock Reports - baoquankhu1.vn
Aug Weekly: Is Revelation Biosciences Inc Equity Warrant stock influenced by commodity pricesForecast Cut & Advanced Technical Signal Analysis - baoquankhu1.vn
Street Watch: Should you avoid LG Display Co Ltd Depositary Receipt stock right now2026 Fundamental Recap & Safe Entry Zone Tips - baoquankhu1.vn
Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development - The Evening Sun
Decliners Report: What is the earnings history of Revelation Biosciences Inc Equity Warrant2026 Major Catalysts & High Accuracy Investment Signals - baoquankhu1.vn
Can Revelation Biosciences Inc. Equity Warrant stock beat analyst upgradesSwing Trade & Expert Curated Trade Ideas - Naître et grandir
Market Review: How does Revelation Biosciences Inc Equity Warrant compare to its peersPortfolio Update Summary & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Risk Analysis: Is Revelation Biosciences Inc Equity Warrant backed by strong institutional buyingJuly 2025 Spike Watch & Smart Allocation Stock Reports - baoquankhu1.vn
History Review: Will Revelation Biosciences Inc Equity Warrant benefit from green energy policiesJuly 2025 Weekly Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
Dividend Watch: Can Revelation Biosciences Inc beat the S P 500Quarterly Market Summary & Low Drawdown Investment Ideas - baoquankhu1.vn
REVB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
EPS Watch: Does Revelation Biosciences Inc Equity Warrant stock benefit from AI growthJuly 2025 Reactions & Community Driven Trade Alerts - baoquankhu1.vn
Weekly Recap: Is enGene Holdings Inc forming bullish engulfing patternsPrice Action & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Activity Recap: What is Revelation Biosciences Inc Equity Warrants valuation compared to sectorEarnings Trend Report & Real-Time Market Trend Scan - baoquankhu1.vn
REVB: 2026 Begins with Financial Picture in Good Shape - Research Tree
Revelation Biosciences Inc Stock (REVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
1.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):